{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T17:06:06Z","timestamp":1788282366818,"version":"build-2803163510"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Allergy"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Traditional Chinese Medicine (TCM) has demonstrated certain efficacy in the treatment of psoriasis, a chronic papulosquamous skin disease. However, in rare instances, the use of TCM may exacerbate cutaneous lesions. This study aims to explore whether the methotrexate (MTX) component in TCM may increase the risk of cutaneous ulceration in patients with psoriasis. MTX is also an immunosuppressive agent widely used in the treatment of various dermatologic conditions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We retrospectively analyzed the medical records of five patients who developed painful skin ulcers at primary psoriatic sites after taking TCM. Evaluated indicators included hemocytopenia, liver function, serum MTX concentration, and ABCB1 gene polymorphisms. Histopathological examination was also performed on ulcerative tissue samples.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among the five patients, two developed hemocytopenia and two had abnormal liver function. Serum MTX concentrations in two patients ranged from 0.03 to 0.11\u2005\u03bcmol\/L (&amp;lt;0.1\u2005\u03bcmol\/L at 72\u2005h after MTX administration). The ABCB1 genotypes AA and AG were detected in two different patients. Histopathological findings revealed dyskeratosis of keratinocytes, dermal vasodilation, and inflammatory cell infiltration. Rescue treatment with oral folic acid was administered to three patients, leading to complete healing of all lesions within two weeks. The remaining two patients showed gradual improvement in skin ulcers after discontinuing TCM.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>TCM containing MTX may induce skin ulceration in rare cases among patients with psoriasis.<\/jats:p><\/jats:sec>","DOI":"10.3389\/falgy.2025.1634055","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T12:27:21Z","timestamp":1750681641000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Painful skin ulcers in psoriasis patients after taking methotrexate-containing traditional Chinese medicine: a retrospective case series"],"prefix":"10.3389","volume":"6","author":[{"given":"Yunhong","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinzi","family":"Dubai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruizhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suju","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,23]]},"reference":[{"key":"B1","first-page":"225","article-title":"Methotrexate: implications of pharmacogenetics in the treatment of patients with rheumatoid arthritis","volume":"1","author":"Torres","year":"2022","journal-title":"ARP Rheumatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"5376","DOI":"10.1200\/JCO.23.00365","article-title":"High-dose methotrexate as CNS prophylaxis in high-risk aggressive B-cell lymphoma","volume":"41","author":"Lewis","year":"2023","journal-title":"J Clin Oncol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1097\/MIB.0000000000001064","article-title":"The influence of methotrexate treatment on male fertility and pregnancy outcome after paternal exposure","volume":"23","author":"Grosen","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"389","DOI":"10.2147\/CCID.S311269","article-title":"Use of methotrexate in the treatment of moderate to severe plaque psoriasis in France: a practice survey","volume":"14","author":"Fougerousse","year":"2021","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.1080\/09546634.2022.2117539","article-title":"Methotrexate dosing regimen for plaque-type psoriasis: an update of a systematic review","volume":"33","author":"van Huizen","year":"2022","journal-title":"J Dermatolog Treat"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e2345132","DOI":"10.1001\/jamanetworkopen.2023.45132","article-title":"Low-dose methotrexate and serious adverse events among older adults with chronic kidney disease","volume":"6","author":"Muanda","year":"2023","journal-title":"JAMA Netw Open"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.3390\/jcm12041599","article-title":"Predicting hepatotoxicity associated with low-dose methotrexate using machine learning","volume":"12","author":"Hu","year":"2023","journal-title":"J Clin Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"7693602","DOI":"10.1155\/2024\/7693602","article-title":"A rare case of acute methotrexate toxicity leading to bone marrow suppression","volume":"2024","author":"Khuwaja","year":"2024","journal-title":"Case Rep Rheumatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1515\/jbcpp-2021-0165","article-title":"Methotrexate related cutaneous adverse drug reactions: a systematic literature review","volume":"33","author":"Zuber","year":"2021","journal-title":"J Basic Clin Physiol Pharmacol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s13555-014-0056-z","article-title":"Methotrexate toxicity during treatment of chronic plaque psoriasis: a case report and review of the literature","volume":"4","author":"Weidmann","year":"2014","journal-title":"Dermatol Ther"},{"key":"B12","doi-asserted-by":"publisher","first-page":"64","DOI":"10.4103\/idoj.IDOJ_157_18","article-title":"Acute methotrexate toxicity due to overdosing in psoriasis: a series of seven cases","volume":"10","author":"Pradhan","year":"2019","journal-title":"Indian Dermatol Online J"},{"key":"B13","first-page":"2","article-title":"Acute methotrexate toxicity seen as plaque psoriasis ulceration and necrosis: a diagnostic clue","volume":"17","author":"Fridlington","year":"2011","journal-title":"Dermatol Online J"},{"key":"B14","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s40257-022-00692-1","article-title":"Methotrexate cutaneous ulceration: a systematic review of cases","volume":"23","author":"Berna","year":"2022","journal-title":"Am J Clin Dermatol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2040622320916026","DOI":"10.1177\/2040622320916026","article-title":"Are gene polymorphisms related to adverse events of methotrexate in patients with rheumatoid arthritis? A retrospective cohort study based on an updated meta-analysis","volume":"11","author":"Huang","year":"2020","journal-title":"Ther Adv Chronic Dis"},{"key":"B16","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/j.1365-4632.2004.02181.x","article-title":"Traditional Chinese medicine is effective and safe in the treatment of psoriasis","volume":"43","author":"Wang","year":"2004","journal-title":"Int J Dermatol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"115275","DOI":"10.1016\/j.jep.2022.115275","article-title":"Potential effects and mechanisms of Chinese herbal medicine in the treatment of psoriasis","volume":"294","author":"Li","year":"2022","journal-title":"J Ethnopharmacol"},{"key":"B18","first-page":"816","article-title":"Deleterious effects of traditional Chinese medicine preparations on the course of psoriasis\u2013a case report","volume":"20","author":"Pietrzak","year":"2013","journal-title":"Ann Agric Environ Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/1523-1747.ep12612745","article-title":"Methotrexate therapy of psoriasis: differential sensitivity of proliferating lymphoid and epithelial cells to the cytotoxic and growth-inhibitory effects of methotrexate","volume":"104","author":"Jeffes","year":"1995","journal-title":"J Invest Dermatol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.bcp.2011.03.020","article-title":"Neurotoxicity of methotrexate to hippocampal cells in vivo and in vitro","volume":"82","author":"Yang","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1177\/039463201002300327","article-title":"Homocysteine, vitamin B12 and folic acid levels in psoriatic patients and correlation with disease severity","volume":"23","author":"Brazzelli","year":"2010","journal-title":"Int J Immunopathol Pharmacol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/s0190-9622(84)70259-3","article-title":"Two patterns of skin ulceration induced by methotrexate in patients with psoriasis","volume":"11","author":"Lawrence","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"458","DOI":"10.2165\/00002512-199609060-00008","article-title":"Use of methotrexate in older patients. A risk-benefit assessment","volume":"9","author":"Tett","year":"1996","journal-title":"Drugs Aging"},{"key":"B24","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1089\/dna.2018.4583","article-title":"ABCB1 (C1236T) polymorphism affects P-glycoprotein-mediated transport of methotrexate, doxorubicin, actinomycin D, and etoposide","volume":"38","author":"Jiang","year":"2019","journal-title":"DNA Cell Biol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1515\/dmpt-2015-0011","article-title":"Association of ABCB1, ABCC5 and xanthine oxidase genetic polymorphisms with methotrexate adverse reactions in Mexican pediatric patients with ALL","volume":"30","author":"Zaruma-Torres","year":"2015","journal-title":"Drug Metab Pers Ther"},{"key":"B26","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2217\/pme-2020-0089","article-title":"ABCB1 And SLCO1B1 gene polymorphisms predict methotrexate-resistant for low-risk gestational trophoblastic neoplasia","volume":"18","author":"Srisuttayasathien","year":"2021","journal-title":"Per Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1111\/jdv.16440","article-title":"The impacts of gene polymorphisms on methotrexate in Chinese psoriatic patients","volume":"34","author":"Chen","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Frontiers in Allergy"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2025.1634055\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T12:27:22Z","timestamp":1750681642000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2025.1634055\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,23]]},"references-count":27,"alternative-id":["10.3389\/falgy.2025.1634055"],"URL":"https:\/\/doi.org\/10.3389\/falgy.2025.1634055","relation":{},"ISSN":["2673-6101"],"issn-type":[{"value":"2673-6101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,23]]},"article-number":"1634055"}}